Jixia Liu1, Zhan Ye2, John G Mayer2, Brian A Hoch2, Clayton Green3, Loren Rolak4, Christopher Cold5, Seik-Soon Khor6, Xiuwen Zheng7, Taku Miyagawa8, Katsushi Tokunaga6, Murray H Brilliant1, Scott J Hebbring1. 1. Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA. 2. Biomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA. 3. Department of Dermatology, Marshfield Clinic, Marshfield, Wisconsin, USA. 4. Department of Neurology, Marshfield Clinic, Marshfield, Wisconsin, USA. 5. Department of Pathology, Marshfield Clinic, Marshfield, Wisconsin, USA. 6. Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 7. Department of Biostatistics, University of Washington, Seattle, Washington, USA. 8. Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Abstract
BACKGROUND: Over 160 disease phenotypes have been mapped to the major histocompatibility complex (MHC) region on chromosome 6 by genome-wide association study (GWAS), suggesting that the MHC region as a whole may be involved in the aetiology of many phenotypes, including unstudied diseases. The phenome-wide association study (PheWAS), a powerful and complementary approach to GWAS, has demonstrated its ability to discover and rediscover genetic associations. The objective of this study is to comprehensively investigate the MHC region by PheWAS to identify new phenotypes mapped to this genetically important region. METHODS: In the current study, we systematically explored the MHC region using PheWAS to associate 2692 MHC-linked variants (minor allele frequency ≥0.01) with 6221 phenotypes in a cohort of 7481 subjects from the Marshfield Clinic Personalized Medicine Research Project. RESULTS: Findings showed that expected associations previously identified by GWAS could be identified by PheWAS (eg, psoriasis, ankylosing spondylitis, type I diabetes and coeliac disease) with some having strong cross-phenotype associations potentially driven by pleiotropic effects. Importantly, novel associations with eight diseases not previously assessed by GWAS (eg, lichen planus) were also identified and replicated in an independent population. Many of these associated diseases appear to be immune-related disorders. Further assessment of these diseases in 16 484 Marshfield Clinic twins suggests that some of these diseases, including lichen planus, may have genetic aetiologies. CONCLUSIONS: These results demonstrate that the PheWAS approach is a powerful and novel method to discover SNP-disease associations, and is ideal when characterising cross-phenotype associations, and further emphasise the importance of the MHC region in human health and disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: Over 160 disease phenotypes have been mapped to the major histocompatibility complex (MHC) region on chromosome 6 by genome-wide association study (GWAS), suggesting that the MHC region as a whole may be involved in the aetiology of many phenotypes, including unstudied diseases. The phenome-wide association study (PheWAS), a powerful and complementary approach to GWAS, has demonstrated its ability to discover and rediscover genetic associations. The objective of this study is to comprehensively investigate the MHC region by PheWAS to identify new phenotypes mapped to this genetically important region. METHODS: In the current study, we systematically explored the MHC region using PheWAS to associate 2692 MHC-linked variants (minor allele frequency ≥0.01) with 6221 phenotypes in a cohort of 7481 subjects from the Marshfield Clinic Personalized Medicine Research Project. RESULTS: Findings showed that expected associations previously identified by GWAS could be identified by PheWAS (eg, psoriasis, ankylosing spondylitis, type I diabetes and coeliac disease) with some having strong cross-phenotype associations potentially driven by pleiotropic effects. Importantly, novel associations with eight diseases not previously assessed by GWAS (eg, lichen planus) were also identified and replicated in an independent population. Many of these associated diseases appear to be immune-related disorders. Further assessment of these diseases in 16 484 Marshfield Clinic twins suggests that some of these diseases, including lichen planus, may have genetic aetiologies. CONCLUSIONS: These results demonstrate that the PheWAS approach is a powerful and novel method to discover SNP-disease associations, and is ideal when characterising cross-phenotype associations, and further emphasise the importance of the MHC region in human health and disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
Genome-Wide Association Study (GWAS); HLA; Precision Medicine; major histocompatibility complex (MHC); phenome-wide association study (PheWAS)
Authors: S Gandolfo; L Richiardi; M Carrozzo; R Broccoletti; M Carbone; M Pagano; C Vestita; S Rosso; F Merletti Journal: Oral Oncol Date: 2004-01 Impact factor: 5.337
Authors: Anurag Verma; Anastasia Lucas; Shefali S Verma; Yu Zhang; Navya Josyula; Anqa Khan; Dustin N Hartzel; Daniel R Lavage; Joseph Leader; Marylyn D Ritchie; Sarah A Pendergrass Journal: Am J Hum Genet Date: 2018-03-29 Impact factor: 11.025
Authors: Elizabeth Blue; Tin L Louie; Jessica X Chong; Scott J Hebbring; Kathleen C Barnes; Nicholas M Rafaels; Michael R Knowles; Ronald L Gibson; Michael J Bamshad; Mary J Emond Journal: Ann Am Thorac Soc Date: 2018-04
Authors: Jennifer A Sinnott; Fiona Cai; Sheng Yu; Boris P Hejblum; Chuan Hong; Isaac S Kohane; Katherine P Liao Journal: J Am Med Inform Assoc Date: 2018-10-01 Impact factor: 4.497
Authors: Cailey I Kerley; Shikha Chaganti; Tin Q Nguyen; Camilo Bermudez; Laurie E Cutting; Lori L Beason-Held; Thomas Lasko; Bennett A Landman Journal: Neuroinformatics Date: 2022-01-03
Authors: Jason H Karnes; Lisa Bastarache; Christian M Shaffer; Silvana Gaudieri; Yaomin Xu; Andrew M Glazer; Jonathan D Mosley; Shilin Zhao; Soumya Raychaudhuri; Simon Mallal; Zhan Ye; John G Mayer; Murray H Brilliant; Scott J Hebbring; Dan M Roden; Elizabeth J Phillips; Joshua C Denny Journal: Sci Transl Med Date: 2017-05-10 Impact factor: 17.956
Authors: Patrick Wu; Aliya Gifford; Xiangrui Meng; Xue Li; Harry Campbell; Tim Varley; Juan Zhao; Robert Carroll; Lisa Bastarache; Joshua C Denny; Evropi Theodoratou; Wei-Qi Wei Journal: JMIR Med Inform Date: 2019-11-29